Entrada Therapeutics Inc.

NASDAQ: TRDA
Share price (3/21/25): $10.49
Market cap (3/21/25): $394 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Registration of securities for employees

Prospectus supplement for primary offering

Registration of securities for employees

Ownership Filter

Wentworth Kory James

Wentworth Kory James

Wentworth Kory James

Dowden Nathan J

News Filter

Reports Fourth Quarter and Full Year 2024 Financial Results

Announces FDA Removal of Clinical Hold on ENTR-601-44

Receives Authorization in the United Kingdom to Initiate ELEVATE-44-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-44 in Patients Living With Duchenne Muscular Dystrophy

Investor Presentation

Reports Third Quarter 2024 Financial Results

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC